Text of amendments, recommended by the committee on Ways and Means (see House document numbered 4891), to the Senate Bill relative to pharmaceutical access, costs and transparency (Senate, No. 2520), as amended by the House. July 24, 2024.
Bill Information
Bill Information
Bill History
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.